Literature DB >> 17193884

Terbutaline pharmacokinetics in cows: preliminary data.

Melanie J Boileau1, Kevin E Washburn, Cyril R Clarke, Robert N Streeter, Lara K Maxwell.   

Abstract

The objective of this study was to determine the serum pharmacokinetics of terbutaline in healthy cows. In the initial experiment, terbutaline was administered once as an intravenous (i.v.) bolus to 6 near-term pregnant beef cows within 24 h after parturition at a low but therapeutically relevant dose, 5 microg/kg. A 2nd experiment was conducted in the same cows with a higher dose, 0.5 mg/kg, but an otherwise similar experimental design. The serum concentration of terbutaline was determined by means of high-performance liquid chromatography with fluorescence detection in both experiments. After i.v. administration of 0.5 mg/kg, the mean peak serum concentration, residence time, and half-life were 708.22 (standard deviation 509.6) ng/mL, 6.75 (3.6) min, and 6.93 (2.4) min, respectively. The results indicate that terbutaline is rapidly eliminated from the bloodstream after i.v. administration in cattle, falling below the assay's limit of detection 30 min after administration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17193884      PMCID: PMC1635991     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  19 in total

1.  Effect of stimulatory and inhibitory drugs on uterine electrical activity measured noninvasively from the abdominal surface of pregnant rats.

Authors:  C S Buhimschi; G R Saade; I A Buhimschi; R Gokdeniz; M B Boyle; R E Garfield
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

2.  Effect of terbutaline on cardiovascular state and uterine blood flow in pregnant ewes.

Authors:  S N Caritis; E Mueller-Heubach; H O Morishima; D I Edelstone
Journal:  Obstet Gynecol       Date:  1977-11       Impact factor: 7.661

3.  Determination of terbutaline enantiomers in human urine by coupled achiral-chiral high-performance liquid chromatography with fluorescence detection.

Authors:  K H Kim; H J Kim; J H Kim; S D Shin
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2001-02-10

4.  Pharmacokinetics of terbutaline after subcutaneous administration.

Authors:  J G Leferink; H Lamont; I Wagemaker-Engels; R A Maes; R Pouwels; M van der Straeten
Journal:  Int J Clin Pharmacol Biopharm       Date:  1979-04

5.  Single injection of terbutaline in term labor. II. Effect on uterine activity.

Authors:  I Ingemarsson; S Arulkumaran; S S Ratnam
Journal:  Am J Obstet Gynecol       Date:  1985-12-15       Impact factor: 8.661

6.  Distribution of terbutaline.

Authors:  A Ryrfeldt; C H Ramsay
Journal:  Eur J Respir Dis Suppl       Date:  1984

7.  Pharmacokinetics of terbutaline after parenteral administration.

Authors:  P O Fagerström
Journal:  Eur J Respir Dis Suppl       Date:  1984

8.  The effects of terbutaline on the acid base balance and circulation of chronically instrumented pregnant sheep.

Authors:  J Ayromlooi; M Tobias; D Desiderio
Journal:  Dev Pharmacol Ther       Date:  1981

9.  Pharmacokinetic parameters of terbutaline in healthy man. An overview.

Authors:  L Nyberg
Journal:  Eur J Respir Dis Suppl       Date:  1984

10.  Intravenous terbutaline and simultaneous beta 1-blockade for advanced premature labor.

Authors:  M G Ross; E Nicolls; P G Stubblefield; J L Kitzmiller
Journal:  Am J Obstet Gynecol       Date:  1983-12-15       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.